Endevica Bio
PrivateLast Round
Series B
Jan 19, 2023
Total Funding Raised
$16.27M
Company Overview
Endevica Bio is a biotechnology company that develops first-in-class peptide drug candidates for the treatment of cachexia caused by cancer and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endevica Bio Comparables
Compare Endevica Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kalohexis | 85% | |
| NGM Biopharmaceuticals | 81% | |
| Actimed Therapeutics | 79% | |
Endevica Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 19, 2023 | ||||
| Grant | Jun 1, 2017 | ||||
| Seed | Jun 1, 2016 |
Key People
Founding team and executive leadership
Endevica Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centennial Investors | Angel, Seed, Series B |
| National Cancer Institute | Grant |
| Missouri Technology Corporation | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2025
Developing a peptide therapeutic drug to combat cachexia.
- Apr 18, 2025
Phase 2 trial initiated for B07, a cancer weight loss treatment.
Endevica Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endevica Bio's valuation, stock price, and market status.